Showing 1 - 4 results of 4 for search 'Pierre Paul eRompre' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Pierre Paul eRompre
Showing 1 - 4 results of 4 for search 'Pierre Paul eRompre', query time: 0.03s Refine Results
  1. 1
    Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.

    Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area. by Charles eDucrot, Emmanuel eFortier, Claude eBouchard, Pierre Paul eRompre

    Published 2013-10-01
    Get full text
    Article
  2. 2
    Ventral midbrain NTS1 receptors mediate conditioned reward induced by the neurotensin analogue, D-Tyr[11]neurotensin

    Ventral midbrain NTS1 receptors mediate conditioned reward induced by the neurotensin analogue, D-Tyr[11]neurotensin by Khalil eRouibi, Poulomee eBose, Pierre Paul eRompre, Richard A Warren

    Published 2015-12-01
    Get full text
    Article
  3. 3
    Dopamine D2 antagonist-induced striatal Nur77 expression requires activation of mGlu5 receptors by cortical afferents

    Dopamine D2 antagonist-induced striatal Nur77 expression requires activation of mGlu5 receptors by cortical afferents by Jérôme eMaheux, Michel eSt-Hilaire, David eVoyer, Emanuele eTirotta, Emiliana eBorrelli, Claude eRouillard, Pierre-Paul eRompré, Daniel eLévesque

    Published 2012-08-01
    Get full text
    Article
  4. 4
    Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine

    Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine by Simon eZhornitsky, Emmanuel eStip, Joelle eDesfosses, Tania ePampoulova, Elie eRizkallah, Elie eRizkallah, Pierre-Paul eRompre, Lahcen Ait Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alain eGendron, Stephane ePotvin

    Published 2011-05-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs